Loading...
Market
Where will the first commercial use of the magnetically controlled prosthetic hand occur by December 31, 2025?
2
Helge Wurdemann•Sara Adela Abad•University College London•UCL•Nature Communications•Science Robotics
Resolution / Starting Odds
By UCL Hospital • 25%
By a US-based hospital • 25%
By a European hospital (excluding UCL) • 25%
By an Asian hospital • 25%
Official announcements from healthcare providers and prosthetic companies
Story
UCL Scientists Develop Advanced Synthetic Touch, Magnetically Controlled Prosthetic Hand with No Artificial Skin
Sep 12, 2024, 11:39 AM
Scientists have made significant advancements in synthetic touch technology, which could transform healthcare. Researchers Helge Wurdemann and Sara Adela Abad from University College London (UCL) developed a bio-inspired haptic system that simulates sensations of touch with high sensitivity, requiring no artificial skin. Additionally, a major medical breakthrough has been achieved with the invention of the world's first magnetically controlled prosthetic hand, which can be controlled by the brain. This prosthetic hand utilizes implanted magnets and pattern recognition algorithms to enable sophisticated movements in users after amputation. The research includes a multiplanar mechano-vibrotactile system using SoftRobotics to deliver intuitive haptic feedback. The research has been published in prominent journals such as Nature Communications and Science Robotics.
View original story
Similar markets
China • 25%
United States • 25%
Europe • 25%
Other • 25%
United States (FDA) • 25%
European Union (EMA) • 25%
Japan (PMDA) • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Yes • 50%
No • 50%
Switzerland • 25%
United States • 25%
European Union • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Communication enhancement for ALS patients • 25%
Cognitive enhancement for general users • 25%
Control of tech devices like Apple Vision Pro • 25%
Medical research and trials • 25%
Yes • 50%
No • 50%
